Cranial Drill Urgent Recall Alert
Serious safety risksUrgent Class I Medical Device Recall
Integra LifeSciences has issued an urgent recall of specific Codman Disposable Perforators and Craniotomy Kits due to a serious manufacturing defect that may lead to device disassembly during neurosurgical procedures. The FDA has classified this as a Class I recall, the most serious type, due to the risk of severe injury or death.
Affected Products
- Codman Disposable Perforator 14 mm – UDI: 10381780513599
- Codman Craniotomy Kit (includes Perforator, Cranio-blade, Wire Pass Drill) – UDI: 10381780513629
Lot/Serial Numbers: Full List of Affected Lots
Reason for Recall
A faulty ultrasonic weld (known as a “proud weld”) on the device’s outer sleeve may cause the perforator to disassemble unexpectedly during use. In some cases, the device fails to disengage properly, putting patients at serious risk for:
- Brain tissue injury
- Bleeding or dural damage
- Extended surgery time
- Irreversible harm or even death
To date, 10 serious injuries have been reported—including devices lodged in the skull and fragments difficult to remove. No fatalities have been reported.
Recommended Actions for Users and Facilities
- Immediately stop using and quarantine all affected products.
- Review inventory against the provided lot numbers.
- Notify surgical and supply staff of the recall.
- Contact Integra for a Return Material Authorization (RMA) and return the product for credit.
Device Function
Codman Disposable Perforators are single-use neurosurgical tools designed to drill precise openings into the skull during craniotomy. They are engineered to disengage automatically after drilling to prevent over-penetration—but this defect undermines that safety feature.
Contact
For questions or to report issues, call Integra LifeSciences at 1-800-654-2873 or email FCA3@integralife.com.
Check the FDA recall web page for updates. The FDA is currently reviewing information about this potentially high-risk device issue and will keep the public informed as significant new information becomes available.
FDA Approves Novel Device for Pancreatic Cancer Treatment
FDA Approves Novel Device for Pancreatic Cancer Treatment The U.S. Food and Drug Administration has approved Optune Pax, a first-of-its-kind medical device designed to treat adult patients with locally advanced pancreatic cancer. Developed by Novocure, the portable...
When Apparel Becomes a Medical Device
Lessons from FDA’s Breast Binder Warning Letters In December 2025, the FDA issued warning letters to several companies selling breast binders and chest compression garments online. The agency concluded that marketing claims on company websites, like statements about...
Labeling Correction for TRUE METRIX® Blood Glucose Meters
Labeling Correction for TRUE METRIX® Blood Glucose Meters Highlights the Critical Role of Clear Error Messaging Trividia Health, Inc. has initiated a labeling correction affecting all TRUE METRIX®, TRUE METRIX AIR®, TRUE METRIX GO®, and TRUE METRIX PRO® blood glucose...